Vimarsana
Biggest News Aggregation in the World

Anthony Dimeo News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Anthony Dimeo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Anthony Dimeo Today - Breaking & Trending Today

Amneal Begins Supplying Over-the-Counter Naloxone Hydrochloride Nasal Spray to U.S. Retail Pharmacies and the State of California - Vimarsana News

Amneal Begins Supplying Over-the-Counter Naloxone Hydrochloride Nasal Spray to U.S. Retail Pharmacies and the State of California

BRIDGEWATER, N.J.--(BUSINESS WIRE)--May 22, 2024--

California cuts cost of overdose-reversal drug by 40% in generic deal - Vimarsana News

California cuts cost of overdose-reversal drug by 40% in generic deal

Under the deal with Amneal Pharmaceuticals, the state will buy twin packs of naloxone nose spray for $24, or about 40 percent less than what it currently pays for a similar product, Governor Gavin Newsom said in a statement Monday.

Amneal and BIAL Announce U.S. Licensing Agreement for ONGENTYS® (opicapone) - Vimarsana News

Amneal and BIAL Announce U.S. Licensing Agreement for ONGENTYS® (opicapone)

ONGENTYS® (opicapone) is a leading adjunctive therapy for the treatment of Parkinson’s DiseaseComplements Amneal’s existing Parkinson’s franchise and further expands specialty portfolioBRIDGEWATER, N.J. & PORTO, Portugal--(BUSINESS WIRE)--Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal”) and BIAL - Portela &...

Amneal Expands Portfolio with Addition of Icosapent Ethyl Acid Soft Gel Capsules - Vimarsana News

Amneal Expands Portfolio with Addition of Icosapent Ethyl Acid Soft Gel Capsules

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Dec 1, 2023--

Amneal Pharmaceuticals, Inc. (NYSE:AMRX) Q3 2023 Earnings Call Transcript - Vimarsana News

Amneal Pharmaceuticals, Inc. (NYSE:AMRX) Q3 2023 Earnings Call Transcript

Anthony DiMeo: Good morning, and thank you for joining Amneal Pharmaceuticals Third Quarter 2023 Earnings Call. Today, we issued a press release reporting our Q3 results.